Everest Biotech Limited
03870943
Some Concerns
- Current liabilities exceed current assets (-10)
- 4 outstanding charges (-8)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 08/05/2019
MANAGING DIRECTOR
AMERICAN · UNITED STATES · Age 60
Also on 1 other board
director · Since 08/05/2019
MANAGING DIRECTOR
AMERICAN · UNITED STATES · Age 37
Also on 1 other board
Persons with Significant Control
Everest Biotech Holdings Limited
Cherwell Innovation Centre, 77 Heyford Park, Upper Heyford, OX25 5HD
Reg: 11971060 · Companies House · Limited Company
Notified 05/11/2025
Former PSCs
Mr Garfield Collins
Ceased 05/07/2018
Mr Garfield Leslie Collins
Ceased 08/05/2019
James Cooper
Ceased 05/11/2025
Charges4 outstanding
AUDAX PRIVATE DEBT LLC AS THE SECURITY AGENT
AUDAX PRIVATE DEBT LLC AS AGENT
ABACUS FINANCE GROUP, LLC
ABACUS FINANCE GROUP, LLC
MADISON CAPITAL FUNDING LLC
CompanyRankvs 5660+ SIC 32990 peers52
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£554
Balance sheet strength
Cash
£386k
Cash in the bank
Net Current Assets
£2.4M
Working capital
Current Assets
£3.2M
Current Liabilities
£794k
Fixed Assets
£4k
Debtors
£2.5M
Tax at Year End
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 3.98 | — |
| 2023 | 3.43 | +£225k |
| 2022 | 10.39 | +£560k |
| 2021 | 7.56 | +£510k |
| 2020 | 5.77 | +£317k |
| 2019 | 2.90 | -£203k |
| 2019 | 3.16 | +£404k |
| 2017 | 4.52 | — |
Derived from filed accounts. Not audited figures.